ADVI Discussed CMS Rx Price Negotiating Staff Transitions with Pink Sheet

Pharmaceuticals and Biotech Federal And State Policy Pharmaceuticals and Biotech

December 8, 2022

December 8, 2022, In this Pink Sheet article, ADVI’s Lindsay Bealor Greenleaf, vice president and head of policy and reimbursement, shares how “CMS will likely shift staff from elsewhere in the agency into some of the Inflation Reduction Act (IRA) implementation roles along with adding new hires.” Read more about Lindsay’s insights and predictions on CMS staffing here.


Reach out

Own your edge

We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.